A Trial of Hetrombopag in Healthy Subjects

NCT05088174 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
26
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Jiangsu HengRui Medicine Co., Ltd.